EDGAR Filing Documents for 0000921895-13-000425

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000921895-13-000425

Filing Date

2013-02-15

Accepted

2013-02-15 17:31:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sc13g07422onc_02072013.htm	SC 13G	198890
2		ex991to13g07422onc_02072013.htm	EX-99.1	30529
	Complete submission text file	0000921895-13-000425.txt		231082

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121

Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100

Oncothyreon Inc. (Subject) CIK: 0001412067 (see all company filings)